Bronchopleural Fistula
2
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
2
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
OcclutechSwitzerland - Schaffhausen
1 programClosure of bronchopleural fistula with Occlutech FigullaN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
Catapult TherapeuticsBPF-001
OcclutechClosure of bronchopleural fistula with Occlutech Figulla
Clinical Trials (2)
Total enrollment: 8 patients across 2 trials
ENgineered Tissue Repair of BronchopleUral FiSTula
Start: Oct 2025Est. completion: Nov 20280
Phase 1/2Withdrawn
Bronchoscopic Closure of Bronchopleural Fistulas With Occlutech Figulla ASD N Occluder Device
Start: Jun 2010Est. completion: Oct 20168 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.